Microenvironment-associated lymph node metastasis of human cervical carcinoma xenografts

Acta Oncologica

Volumn 51, Issue 4, 2012, Pages 465-472

  Ellingsen, Christine ^a   Hompland, Tord ^a   Mathiesen, Berit ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIC CELL; INTERSTITIAL FLUID; LYMPH NODE METASTASIS; METASTASIS; MICROENVIRONMENT; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; RADIOBIOLOGY; UTERINE CERVIX CARCINOMA; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; EXTRACELLULAR FLUID; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LYMPHATIC METASTASIS; MICE; MICE, INBRED BALB C; MICE, NUDE; PELVIC NEOPLASMS; PROGNOSIS; TUMOR MICROENVIRONMENT; UTERINE CERVICAL NEOPLASMS;

EID: 84859742382     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.636751     Document Type: Article

References (38)

1. Barbera L, Thomas G. Management of early and locally advanced cervical cancer. Semin Oncol 2009;36:155-69.
2. Harry VN, Gilhert FJ, Parkin DE. Predicting the response of advanced cervical and ovarian tumors to therapy. Obstet Gynecol Surv 2009;64:548-60.
3. Vaupel P, Mayer A. Hypoxia in cancer: Signifi cance and impact on clinical outcome. Cancer Metastasis Rev 2007;26: 225- 39.
4. Vaupel P, Kallinowski F, Okunieff P. Blood fl ow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 1989;49:6449- 65.
5. Vordermark D, Brown JM. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance. Strahlenther Onkol 2003;179:801-11.
6. 2 tension measurements. Cancer Res 1991;51:6098-102.
7. Milosevic M, Fyles A, Hedley D, Pintilie M, Levin W, Manchul L, et al. Interstitial fl uid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res 2001;61:6400-5.
8. Schwickert G, Walenta S, Sundfør K, Rofstad EK, Mueller- Klieser W. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 1995;55: 4757-9.
9. Rofstad EK. Microenvironment-induced cancer metastasis. Int J Radiat Biol 2000;76:589-605.
10. Höc kel M, Vaupel P. Tumor hypoxia: Defi nitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001;93:266-76.
11. Subarsky P, Hill RP. The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 2003;20: 237-50.
12. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45-50.
13. Höc kel M, Schlenger K, Aral B, Mitze M, Schäf fer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-15.
14. Fyles AW, Milosevic M, Wong R, Kavanagh MC, Pintilie M, Sun A, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998;48:149-56.
15. Sundfør K, Lyng H, Tropé CG, Rofstad EK. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: Relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol 2000;54:101-7.
16. Fyles A, Milosevic M, Pintilie M, Syed A, Levin W, Manchul L, et al. Long-term performance of interstitial fl uid pressure and hypoxia as prognostic factors in cervix cancer. Radiother Oncol 2006;80:132-7.
17. Yeo SG, Kim JS, Cho MJ, Kim KH, Kim JS. Interstitial fl uid pressure as a prognostic factor in cervical cancer following radiation therapy. Clin Cancer Res 2009;15:6201-7.
18. Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfør K, Rofstad EK, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 2000;60:916-21.
19. Ellingsen C, Natvig I, Gaustad JV, Gulliksrud K, Egeland TAM, Rofstad EK. Human cervical carcinoma xenograft models for studies of the physiological microenvironment of tumors. J Cancer Res Clin Oncol 2009;135:1177-84.
20. Ozerdem U, Hargens AR. A simple method for measuring interstitial fl uid pressure in cancer tissues. Microvasc Res 2005;70:116-20.
21. Rofstad EK, Mås eide K. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: Acute and chronic hypoxia in individual tumours. Int J Radiat Biol 1999;75:1377-93.
22. Rofstad EK, Galappathi K, Mathiesen B, Ruud EBM. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin Cancer Res 2007;13:1971 - 8.
23. Ellingsen C, Egeland TAM, Gulliksrud K, Gaustad JV, Mathiesen B, Rofstad EK. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2009;73:838-45.
24. Hall EJ. Radiobiology for the radiologist. Philadelphia: Lippincott Wiliams & Wilkins; 2000. pp. 91 - 111.
25. Gulledge CJ, Dewhirst MW. Tumor oxygenation: A matter of supply and demand. Anticancer Res 1996;16:741- 50.
26. Stubbs M, McSheehy PMJ, Griffi ths JR, Bashford CL. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 2000;6:15-9.
27. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nature Rev Cancer 2002;2:38-47.
28. Chan DA, Giaccia A. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev 2007;26:333-9.
29. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1 ? is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000;60:4693-6.
30. Burri P, Djonov V, Aebersold DM, Lindel K, Studer U, Altermatt HJ, et al. Signifi cant correlation of hypoxiainducible factor-1 with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003;56:494-501.
31. Ishikawa H, Sakurai H, Hasegawa M, Mitsuhashi N, Takahashi M, Masuda N, et al. Expression of hypoxic-inducible factor 1 predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2004;60:513-21.
32. Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, et al. Glucose transporter Glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 2001;7:928-34.
33. Loncaster JA, Cooper RA, Logue JP, Davidson SE, Hunter RD, West CML. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. Br J Cancer 2000;83:620-5.
34. Rofstad EK, Tunheim SH, Mathiesen B, Graff BA, Halsør EF, Nilsen K, et al. Pulmonary and lymph node metastasis is associated with primary tumor interstitial fl uid pressure in human melanoma xenografts. Cancer Res 2002;62: 661-4.
35. Hoshida T, Isaka N, Hagendoorn J, di Tomaso E, Chen YL, Pytowski B, et al. Imaging steps of lymphatic metastasis reveal that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: Therapeutic implications. Cancer Res 2006;66:8065-75.
36. Rofstad EK, Mathiesen B, Kindem K, Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 2006; 66:6699-707.
37. Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu L, Sloane BF, et al. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 2009;69: 2260-8.
38. Jain RK. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 2005;307: 58-62.